Stock Events

Bio-Rad Laboratories 

€256
90
+€0+0% 今天

統計

當日最高
256
當日最低
256
52週最高
-
52週最低
-
成交量
0
平均成交量
-
市值
7.88B
市盈率
-
股息收益率
-
股息
-

收益

7May確認
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
2.15
2.63
3.11
3.59
預期每股收益
2.15
實際每股收益
2.29

人們還關注

此列表基於在 Stock Events 上關注 BUW.F 的人的關注列表。這不是投資建議。

競爭者

這個列表是基於最近市場事件的分析。這不是投資建議。

關於

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Show more...
首席執行官
Mr. Norman D. Schwartz
員工
8000
國家
US
ISIN
US0905721082
WKN
000862449

上市公司